The Motley Fool

Neil Woodford Buys More Legal & General Group Plc, BAE Systems plc, Centrica PLC, SSE PLC & RM2 International SA

What with the run-up to the General Election and the launch of his Patient Capital Trust — focused on fledgling growth companies — I didn’t expect Neil Woodford to be particularly busy tending to the more mature stocks of his established Woodford Equity Income Fund.

However, April proved to be a busier month than usual. A number of trades caught my eye among Woodford’s latest dealings: in particular, additions to his holdings in Legal & General (LSE: LGEN), BAE Systems (LSE: BA), Centrica (LSE: CNA), SSE (LSE: SSE) and RM2 International (LSE: RM2).

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

There’s only one blue-chip financial, one blue-chip financial…

Woodford continues to be less than keen on big FTSE 100 banks and insurers. In fact, he holds only one financial company from the blue-chip “premier league”, and that’s Legal & General.

Woodford’s team describes the life insurance industry as having been “opaque and unpredictable” historically, but sees, with L&G’s “relentless focus on cash generation”, a chief executive “transforming the business into a much simpler, easier to understand business with strong growth prospects”.

L&G trades on an undemanding forward P/E of 14, while the prospective dividend yield — to which Woodford remains attracted — is about 5%.

RM2, RM who?

AIM-listed RM2 International will not be as well-known to most investors as the likes of L&G. The pallet-maker “is still at an early-stage of its development but has tremendous potential to disrupt the pallet industry”, and Woodford is very keen on the company.

In adding to his holding, his fund update noted that RM2’s “recent contract win with PPG International [an S&P 500/Fortune 200 company] is very positive news, in our view, and could herald the broader adoption of its composite pallets”.

RM2 is loss-making at present, but revenues are forecast to leap from £18m this year to £65m next year, with the company starting to move towards profitability.

3 blue chips bulked up

Back to the FTSE 100, and Woodford added to a number of blue chips — that “demonstrated weakness in the run-up to the General Election” — at “what we consider to be attractive valuation levels”. These companies included BAE Systems, Centrica and SSE — described by Woodford’s team as “important income contributors”.

The shares of “Big Six” energy firms Centrica and SSE had been under the cloud of potential Labour Party meddling, but have rallied on the back of the Tory election victory. As such, investors today won’t get quite as high a yield as Woodford was able to secure, although the prospective income from the pair remains attractively above the market average: Centrica at 4.4% and SSE at 5.5%.

Conversely, BAE’s shares are currently a bit lower than when Woodford was buying, so investors today are getting a slightly better yield deal. The prospective income from BAE is 4.2%.

Other “important income contributors” that came in for top-ups during April were GlaxoSmithKline, Game Digital, Next and Royal Mail, while the fund “marginally trimmed” its position in BT, “where the share price is now back at levels not seen since early 2001”.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US $12.3 TRILLION out of thin air…

And if you click here, we’ll show you something that could be key to unlocking 5G’s full potential...

It’s just ONE innovation from a little-known US company that has quietly spent years preparing for this exact moment…

But you need to get in before the crowd catches onto this ‘sleeping giant’.

Click here to learn more.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended Centrica and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.